Jamie Mantzouridis says years of steroid, growth hormone and insulin use led to serious side effects before he quit after feeling dangerously dizzy.
A leading doctor has warned that online sales of experimental peptides, steroids and similar substances are creating serious health risks in the UK, with oversight split across regulators and social media platforms.
After rallying to a four-month high on Wednesday, European stock markets fell yet again on Thursday morning as investors continue to express anxiety over the ongoing uncertainty surrounding the Omicron coronavirus variant.
Since first being detected in Southern Africa, the Omicron variant has spread to Europe and the U.K. While...
Stock futures in New York gained on Wednesday after experiencing a day of mass sell-offs amid hysteria surrounding the Omicron coronavirus variant and the uncertain impact that it may have on the economy.
After closing at nearly 2% lower on Tuesday afternoon, S&P 500 futures rose by 1.22% after trading...
As the G20 conference in Rome gets underway, the United Kingdom has committed to delivering up to 20 million additional doses of coronavirus vaccines to developing nations in an effort to fuel the global post-pandemic economic recovery.
This pledge comes after Britain committed itself earlier in the year at a...
Merck & Co announced on Wednesday that it has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) to allow other companies to manufacture generic versions of the U.S. drugmaker's oral antiviral COVID-19 treatment. The agreement would be valid in 105 low and middle-income countries.
The experimental...
The Canadian province of Ontario revealed its plan to lift several COVID-19 health restrictions. Starting from Saturday at midnight, concert venues, theatres, sports stadiums, and other spectator facilities will be permitted to host a higher capacity of spectators than was previously permitted. Spectators will still, however, be required to...
Brain disease drug developer Neumora Therapeutics received a $100 million equity investment from U.S. biotech firm Amgen Inc. As a result, Neumora will receive global rights to produce and distribute some of Amgen's experimental drugs aimed at neurodegenerative diseases.
Together with the $400 million that the company raised from investors...
Johnson & Johnson revealed recently that it has begun the process of seeking emergency use authorization of the booster shot for its COVID-19 vaccine for people 18 years of age and older. In order to embark on the process, the pharmaceutical giant submitted data to the U.S. Food and...
Britain's antiviral taskforce chair Eddie Gray hinted at Britain's interest in buying the molnupiravir, an experimental oral COVID-19 drug developed by Merck & Co Inc.
While Gray declined to comment directly on any potential talks being held between Britain and Merck & Co Inc, he did mention the following: "We...